Markers of inflammation and mortality in a cohort of patients with alcohol dependence

Medicine (United States)

Volumn 94, Issue 10, 2015, Pages

  Fuster, Daniel ^a   Sanvisens, Arantza ^a   Bolao, Ferran ^b   Zuluaga, Paola ^a   Rivas, Inmaculada ^c   Tor, Jordi ^a   Muga, Robert ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c (Centro Delta) IMSP Badalona   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FIBRINOGEN; HEMOGLOBIN; HEPATITIS B SURFACE ANTIGEN;

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER DISEASE; ALCOHOL USE DISORDER; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANEMIA; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DISEASE MARKER; FEMALE; FERRITIN BLOOD LEVEL; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MACROCYTIC ANEMIA; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; MICROCYTIC ANEMIA; MORTALITY; PRIORITY JOURNAL; THROMBOCYTE COUNT; BLOOD; CARDIOVASCULAR DISEASE; LONGITUDINAL STUDY;

ADULT; ALCOHOLISM; ANEMIA; CARDIOVASCULAR DISEASES; COHORT STUDIES; ERYTHROCYTE INDICES; FEMALE; FERRITINS; FIBRINOGEN; HUMANS; INFLAMMATION; LIVER DISEASES, ALCOHOLIC; LONGITUDINAL STUDIES; MALE;

EID: 84929035646     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000000607     Document Type: Article

References (38)

1. Saitz R. Clinical practice. Unhealthy alcohol use. N Engl J Med. 2005;352:596-607.
2. Schuckit MA. Alcohol-use disorders. Lancet. 2009;373:492-501.
3. O'Shea RS, Dasarathy S, McCullough AJ. Practice Guideline Committee of the American Association for the Study of Liver Diseases. Practice Parameters Committee of the American College of Gastroenterology. Alcoholic liver disease. Hepatology. 2010;51:307-328.
4. Ministerio de Sanidad, Servicios Sociales e Igualdad. Encuesta Nacional Salud en Espana, 2011. Available at: http://www.msssi.-gob.es/estadEstudios/estadisticas/encuestaNacional/home.htm. Accessed October 30, 2014.
5. Mokdad AH, Marks JS, Stroup DF, et al. Actual causes of death in the United States, 2000. JAMA. 2004;291:1238-1245.
6. Rehm J, Taylor B, Mohapatra S, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010;29:437-445.
7. Bellentani S, Saccoccio G, Costa G, et al. Drinking habits as cofactors of risk for alcohol induced liver damage. The Dionysos Study Group. Gut. 1997;41:845-850.
8. Rivas I, Sanvisens A, Bolao F, et al. Impact of medical comorbidity and risk of death in 680 patients with alcohol use disorders. Alcohol Clin Exp Res. 2013;37(Suppl 1):E221-E227.
9. Rao RK, Seth A, Sheth P. Recent Advances in Alcoholic Liver Disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol liver Physiol. 2004;286:G881-G884.
10. Mandrekar P, Szabo G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol. 2009;50:1258-1266.
11. Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol. 1987;4:8-14.
12. Szabo G, Bala S. Alcoholic liver disease and the gut-liver axis. World J Gastroenterol. 2010;16:1321-1329.
13. Tien PC, Choi AI, Zolopa AR, et al. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort. J Acquir Immune Defic Syndr. 2010;55:316-322.
14. Kuller LH, Tracy R, Belloso W, et al. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection. PLoS Med. 2008;5:e203.
15. Fuster D, Cheng DM, Quinn EK, et al. Inflammatory cytokines and mortality in a cohort of HIV-infected adults with alcohol problems. AIDS. 2014;28:1059-1064.
16. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med. 2005;352:1011-1023.
17. Dayer E, Dayer J-M, Roux-Lombard P. Primer: the practical use of biological markers of rheumatic and systemic inflammatory diseases. Nat Clin Pract Rheumatol. 2007;3:512-520.
18. Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol. 2012;34:43-62.
19. Muga R, Sanvisens A, Fuster D, et al. Unhealthy alcohol use, HIV infection and risk of liver fibrosis in drug users with hepatitis C. PLoS One. 2012;7:e46810.
20. World Health Organization. Iron deficiency anaemia: assessment, prevention and control. 2001. Available at: http://www.who.int/nutrition/publications/en/ida-assessment-prevention-control.pdf. Accessed October 30, 2014.
21. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med. 2009;360:2758-2769.
22. Robins LN, Wing J, Wittchen HU, et al. The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures. Arch Gen Psychiatry. 1988;45:1069-1077.
23. Fuster D, Sanvisens A, Bolao F, et al. Impact of hepatitis C virus infection on the risk of death of alcohol-dependent patients. J Viral Hepat. 2015;22:18-24.
24. Von Haehling S, van Veldhuisen DJ, Roughton M, et al. Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study. Eur J Heart Fail. 2011;13:656-663.
25. Hao Z, Wu B, Wang D, et al. A cohort study of patients with anemia on admission and fatality after acute ischemic stroke. J Clin Neurosci. 2013;20:37-42.
26. Lin J-N, Tsai Y-S, Lai C-H, et al. Risk factors for mortality of bacteremic patients in the emergency department. Acad Emerg Med. 2009;16:749-755.
27. Plakht Y, Shiyovich A, Gilutz H. Predictors of long-term (10-year) mortality postmyocardial infarction: age-related differences. Soroka Acute Myocardial Infarction (SAMI) Project. J Cardiol. 2014; S0914-5087: 00171-3.
28. Dunne JR, Malone D, Tracy JK, et al. Perioperative anemia: an independent risk factor for infection, mortality, and resource utilization in surgery. J Surg Res. 2002;102:237-244.
29. Horie Y, Ishii H, Hibi T. Severe alcoholic hepatitis in Japan: prognosis and therapy. Alcohol Clin Exp Res. 2005;29(12 Suppl):251S-258S.
30. Latvala J, Parkkila S, Niemelä O. Excess alcohol consumption is common in patients with cytopenia: studies in blood and bone marrow cells. Alcohol Clin Exp Res. 2004;28:619-624.
31. Savage D, Lindenbaum J. Anemia in alcoholics. Medicine (Baltimore). 1986;65:322-338.
32. Boulware DR, Hullsiek KH, Puronen CE, et al. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death. J Infect Dis. 2011;203:1637-1646.
33. Sandler NG, Wand H, Roque A, et al. Plasma levels of soluble CD14 independently predict mortality in HIV infection. J Infect Dis. 2011;203:780-790.
34. Sandler NG, Koh C, Roque A, et al. Host response to translocated microbial products predicts outcomes of patients with HBV or HCV infection. Gastroenterology. 2011;141:1220-1230.
35. Okwuosa TM, Klein O, Chan C, et al. Long-term change in alcoholconsumption status and variations in fibrinogen levels: the coronary artery risk development in young adults (CARDIA) study. BMJ Open. 2013;3:e002944.
36. Brien SE, Ronksley PE, Turner BJ, et al. Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies. BMJ. 2011;342:d636.
37. Lieb M, Palm U, Hock B, et al. Effects of alcohol consumption on iron metabolism. Am J Drug Alcohol Abuse. 2011;37:68-73.
38. Vidali M, Occhino G, Ivaldi A, et al. Combination of oxidative stress and steatosis is a risk factor for fibrosis in alcohol-drinking patients with chronic hepatitis C. Am J Gastroenterol. 2008;103:147-153.